Medicare Enrolled
Dr. Shalin Shah, M.D.
Internal Medicine · Plainfield, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Shalin Shah is an internal medicine specialist in Plainfield, IL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 60,035 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shah received a total of $6,381 from 54 pharmaceutical and/or device companies across 235 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years of NPI registration
▲ Top 0% volume in IL
$6,381 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗60,035
Medicare services
Top 0% in IL for internal medicine
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
22,440 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
8,250 | $0 | $3 |
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
7,500 | $17 | $34 |
| Paclitaxel chemotherapy injection | 5,424 | $0 | $5 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
5,075 | $34 | $81 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
2,190 | $35 | $257 |
| Denosumab injection (Prolia/Xgeva) | 2,100 | $19 | $27 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,204 | $0 | $1 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,200 | $26 | $149 |
| Anti-nausea injection (Aloxi/palonosetron) | 560 | $1 | $142 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
523 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
457 | $8 | $40 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
292 | $13 | $54 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
282 | $101 | $229 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
281 | $52 | $201 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
279 | $10 | $55 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
210 | $109 | $380 |
| Iron level test | 131 | $6 | $33 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
131 | $9 | $45 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
108 | $13 | $70 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
108 | $6 | $416 |
| New patient office visit, complex (60-74 min) | 101 | $176 | $443 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
96 | $11 | $62 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
96 | $23 | $95 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
95 | $24 | $95 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
86 | $1 | $3 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
71 | $17 | $70 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
69 | $4 | $15 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
63 | $64 | $179 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
59 | $15 | $77 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
59 | $14 | $77 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
56 | $54 | $189 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
56 | $65 | $151 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
53 | $106 | $295 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
51 | $2 | $23 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
50 | $27 | $156 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $145 | $307 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
37 | $1 | $10 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
29 | $6 | $30 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
23 | $4 | $21 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
21 | $4 | $18 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
21 | $6 | $33 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
19 | $19 | $67 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
14 | $5 | $26 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
13 | $26 | $95 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $143 | $431 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
65.3% high complexity
30.5% medium
4.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,381
Total received (2021-2024)
Avg $1,595/year across 4 years
Top 10% in IL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
235
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,562
2023
$3,098
2022
$1,464
2021
$257
Payments by company (2024)
Avyxa Pharma, LLC
$424
Lilly USA, LLC
$157
AstraZeneca Pharmaceuticals LP
$128
PFIZER INC.
$87
Novartis Pharmaceuticals Corporation
$79
Merck Sharp & Dohme LLC
$78
ABBVIE INC.
$76
BeiGene USA, Inc.
$49
Gilead Sciences, Inc.
$47
E.R. Squibb & Sons, L.L.C.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$43
JAZZ PHARMACEUTICALS INC.
$39
Genentech USA, Inc.
$37
Janssen Biotech, Inc.
$26
Eisai Inc.
$24
Celgene Corporation
$23
SERVIER PHARMACEUTICALS LLC
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Dendreon Pharmaceuticals LLC
$22
Incyte Corporation
$21
GENZYME CORPORATION
$21
Alexion Pharmaceuticals, Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$18
Apellis Pharmaceuticals, Inc.
$18
Coherus Biosciences Inc.
$17
Astellas Pharma US Inc
$16
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2021-2024) ›
Lilly USA, LLC
$459
Avyxa Pharma, LLC
$424
Seagen Inc.
$410
AstraZeneca Pharmaceuticals LP
$394
Novartis Pharmaceuticals Corporation
$364
Astellas Pharma US Inc
$333
Incyte Corporation
$313
Merck Sharp & Dohme LLC
$285
Genentech USA, Inc.
$266
Daiichi Sankyo Inc.
$252
Amgen Inc.
$221
PFIZER INC.
$209
E.R. Squibb & Sons, L.L.C.
$200
Janssen Biotech, Inc.
$198
Eisai Inc.
$177
GENZYME CORPORATION
$131
Gilead Sciences, Inc.
$130
G1 Therapeutics, Inc.
$108
Celgene Corporation
$100
Takeda Pharmaceuticals U.S.A., Inc.
$97
BeiGene USA, Inc.
$88
Alexion Pharmaceuticals, Inc.
$85
Regeneron Healthcare Solutions, Inc.
$84
ABBVIE INC.
$76
JAZZ PHARMACEUTICALS INC.
$71
Mirati Therapeutics, Inc.
$70
Coherus Biosciences Inc.
$63
AbbVie Inc.
$56
ARRAY BIOPHARMA INC
$50
Exelixis Inc.
$45
SERVIER PHARMACEUTICALS LLC
$44
Pharmacyclics LLC, An AbbVie Company
$43
Bayer Healthcare Pharmaceuticals Inc.
$40
Ipsen Biopharmaceuticals, Inc
$39
Kite Pharma, Inc.
$37
TerSera Therapeutics LLC
$36
SOBI, INC
$36
Medtronic, Inc.
$36
Blueprint Medicines Corporation
$26
Adaptive Biotechnologies Corporation
$24
EMD Serono, Inc.
$24
Dendreon Pharmaceuticals LLC
$22
Kyowa Kirin, Inc.
$21
Telix Pharmaceuticals
$20
EISAI INC.
$20
Lundbeck LLC
$20
PUMA BIOTECHNOLOGY, INC.
$18
Apellis Pharmaceuticals, Inc.
$18
AVEO Pharmaceuticals, Inc.
$18
Janssen Pharmaceuticals, Inc
$17
TAIHO ONCOLOGY, INC.
$17
CTI BioPharma Corp.
$16
GlaxoSmithKline, LLC.
$16
Novo Nordisk Inc
$13
Top 3 companies account for 20.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ANDEXXA · AYVAKIT · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · Docivyx · Doptelet · ELIQUIS · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · FOTIVDA · FRUZAQLA · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JAYPIRCA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · LIBTAYO · LONSURF · LUMAKRAS · Lenvima · Lunsumio · MEKINIST · MONJUVI · NINLARO · Nplate · Nubeqa · OMVOH · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION · Onivyde · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · REBLOZYL · RYBELSUS · SARCLISA · SCEMBLIX · TABRECTA · TAGRISSO · TECENTRIQ · TEPMETKO · TEVIMBRA · TREMFYA · TUKYSA · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VYEPTI · Venclexta · Vonjo · XARELTO · Xermelo · Xtandi · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
1,632
County median income
$107,799
Nearest hospital to ZIP centroid (approximate)
COPLEY MEMORIAL HOSPITAL
6.2 mi
6.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a mixed practice specialist, with above-average Medicare volume (top 0% in IL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Shah performed 22,440 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $6,381 from 54 companies across 235 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other internal medicine physicians in Plainfield?
Dr. Shah's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Plainfield
Browse internal medicine physicians in Plainfield ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in IL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in IL
Which IL internal medicine physicians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Avyxa Pharma, LLC Payments to Doctors
See all physicians who received payments from Avyxa Pharma, LLC.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology